| abstract |
The present invention relates to a method for treatment or prevention of a non-ischemic condition in one or more organs, the method comprising administering an effective dosage of alpha -MSH and/or an alpha -MSH equivalent and/or EPO and/or an EPO equivalent to a person in need thereof. In particular, the invention relates to the treatment of inflammation under non-ischemic conditions. Non-limiting examples of such conditions are: Asthma, arthritis, psoriasis, infections, systemic lupus erythematosus, Systemic Sclerosis, allergic rhinitis, allergic and non-allergic conjunctivitis. Moreover, inflammatory diseases also include allergic and non-allergic dermatitis. |